Detalles de la búsqueda
1.
Clinical significance of Bacteroides fragilis as a potential prognostic factor in colorectal cancer.
Anaerobe
; 84: 102784, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37806638
2.
The Efficacy of Immunotherapy and Clinical Utility of Comprehensive Genomic Profiling in Adenoid Cystic Carcinoma of Head and Neck.
Medicina (Kaunas)
; 59(12)2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38138214
3.
Role of enterocyte-specific gene polymorphisms in response to adjuvant treatment for stage III colorectal cancer.
Pharmacogenet Genomics
; 31(1): 10-16, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32732498
4.
Clinical significance of enterocyte-specific gene polymorphisms as candidate markers of oxaliplatin-based treatment for metastatic colorectal cancer.
Pharmacogenomics J
; 21(3): 285-295, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33542444
5.
Serum IL-8 level as a candidate prognostic marker of response to anti-angiogenic therapy for metastatic colorectal cancer.
Int J Colorectal Dis
; 36(1): 131-139, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32920703
6.
Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research.
Int J Clin Oncol
; 26(2): 335-344, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33085057
7.
Epidermal growth factor receptor mRNA expression: A potential molecular escape mechanism from regorafenib.
Cancer Sci
; 111(2): 441-450, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31821662
8.
A phase I study to determine the maximum tolerated dose of trifluridine/tipiracil and oxaliplatin in patients with refractory metastatic colorectal cancer: LUPIN study.
Invest New Drugs
; 38(1): 111-119, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30838483
9.
Clinical utility of polyethylene glycol conjugated granulocyte colony-stimulating factor (PEG-G-CSF) for preventing severe neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI plus bevacizumab: a single-center retrospective study.
BMC Cancer
; 20(1): 358, 2020 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32345249
10.
Non-V600E BRAF mutations and EGFR signaling pathway in colorectal cancer.
Int J Cancer
; 145(9): 2488-2495, 2019 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30963570
11.
Genetic variants in CCL5 and CCR5 genes and serum VEGF-A levels predict efficacy of bevacizumab in metastatic colorectal cancer patients.
Int J Cancer
; 144(10): 2567-2577, 2019 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30411783
12.
Phase II Trial of Neoadjuvant Chemotherapy, Chemoradiotherapy, and Laparoscopic Surgery with Selective Lateral Node Dissection for Poor-Risk Low Rectal Cancer.
Ann Surg Oncol
; 26(8): 2507-2513, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30963400
13.
Association of Hand-Foot Skin Reaction with Regorafenib Efficacy in the Treatment of Metastatic Colorectal Cancer.
Oncology
; 96(4): 200-206, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30763946
14.
Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer.
Gastric Cancer
; 22(3): 518-525, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30328533
15.
Correction to: Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer.
Gastric Cancer
; 22(3): 526, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30467737
16.
Phase II trial of biweekly cetuximab and irinotecan as third-line therapy for pretreated KRAS exon 2 wild-type colorectal cancer.
Cancer Sci
; 109(8): 2567-2575, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29908105
17.
Potential role of PIN1 genotypes in predicting benefit from oxaliplatin-based and irinotecan-based treatment in patients with metastatic colorectal cancer.
Pharmacogenomics J
; 18(5): 623-632, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29925895
18.
Serum leucine-rich alpha-2-glycoprotein-1 with fucosylated triantennary N-glycan: a novel colorectal cancer marker.
BMC Cancer
; 18(1): 406, 2018 04 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29642865
19.
Single nucleotide polymorphisms in the IGF-IRS pathway are associated with outcome in mCRC patients enrolled in the FIRE-3 trial.
Int J Cancer
; 141(2): 383-392, 2017 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28369940
20.
Predictive value of TLR7 polymorphism for cetuximab-based chemotherapy in patients with metastatic colorectal cancer.
Int J Cancer
; 141(6): 1222-1230, 2017 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28569041